Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-31

Clinical Trial Update: Imaging of Solid Tumors Using FAP-2286 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial exploring imaging of solid tumors in adults using the FAP-2286 tracer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FAP-2286

Snippet

Sponsor: Thomas Hope | Conditions: Solid Tumors, Adult, Metastatic Cancer | Phase 1 | Status: RECRUITING